Advanced Research Training in Immunology for Surgery Trainees (ARTIST)
外科实习生免疫学高级研究培训 (ARTIST)
基本信息
- 批准号:10180880
- 负责人:
- 金额:$ 33.69万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-08-15 至 2024-07-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Project Summary/Abstract
The Advanced Research Training in Immunology for Surgery Trainees (ARTIST) is a specialized training
program that responds to the accelerating demand for expertise at the intersection of surgery and translational
immunology research and the critical need to ensure a pipeline of surgeon-scientists. The long-term goal of
the program is to inspire and train the next generation of surgeon-scientists who will lead immunology research
focused on solutions for clinical problems relevant to tissue injury, repair, regeneration and replacement.
Discoveries by these surgeon-scientists are anticipated to lead to new tools for diagnosis or prognosis of
immune-mediated diseases and also to new immunotherapies. Program objectives are achieved by
recruitment of outstanding trainees with innate curiosity and the aspiration to become leaders in surgery,
selection of high quality interdisciplinary and collaborative NIH-funded faculty, and innovative didactics and
professional development activities. Eligible trainees are competitively selected from an outstanding pool of
surgery residents (postdoctoral trainees) in the Ohio State University (OSU) General Surgery residency
program who have completed at least two years of clinical training. The diversity of the surgical trainee pool is
a strength of the ARTIST program since the diversity of its research trainees will contribute greatly to the
quality and diversity of the future biomedical research workforce. Surgical trainees work with the program
director, faculty and staff to prepare for the research experience far in advance of the training period in order to
optimize their research success and productivity. Each trainee dedicates a minimum of two years without
clinical responsibilities to conduct mentored research, to undergo didactic training in the OSU COM Masters of
Medical Science advanced degree program and to participate in professional development activities. Following
completion of the research training program, trainees proceed to another two to three years of advanced
clinical training. During this time they continue to publish, present at national meetings, compete for awards
and participate in research and professional development activities associated with the program. With this
renewal application, we are requesting funds for training four postdoctoral trainees per year for Years 1
through 5. Core requirements to earn the MMS degree include coursework in Immunology, Research Design,
Biostatistics, Grant Writing, and Research Ethics. Trainees are also required to take two newly developed
courses “Career Development for Surgeons” course and “Applications of Immunology in Surgery” journal club.
Significant programmatic attention is directed to seamless integration of the clinical and research training
programs, ensuring the quality and rigor of the curriculum, facilitating opportunities to enhance science
communication skills, creation of innovative educational assessment tools, careful evaluation of individual
trainee progress and collective evaluation of program outcomes.
项目总结/摘要
外科学员免疫学高级研究培训(ARTIST)是一项专业培训,
该计划旨在应对手术和翻译交叉点对专业知识的不断增长的需求
免疫学研究和确保外科医生科学家管道的迫切需要。的长期目标
该项目旨在激励和培训下一代外科医生科学家,他们将领导免疫学研究
专注于解决与组织损伤、修复、再生和替换相关的临床问题。
这些外科医生-科学家的发现预计将导致新的诊断或预后工具,
免疫介导的疾病以及新的免疫疗法。计划目标通过以下方式实现:
招募具有天生好奇心和成为外科领导者愿望的优秀学员,
选择高质量的跨学科和合作NIH资助的教师,和创新的教学法,
专业发展活动。合格的学员是从一个优秀的人才库中竞争性地挑选出来的,
俄亥俄州州立大学(OSU)普通外科住院医师(博士后实习生)
计划谁已经完成了至少两年的临床培训。外科实习生的多样性
艺术家计划的优势,因为其研究学员的多样性将大大有助于
未来生物医学研究队伍的质量和多样性。外科实习生与该计划合作
主任,教师和工作人员准备的研究经验远远提前的培训期,以
优化他们的研究成果和生产力。每名受训人员至少要工作两年,
临床责任进行指导研究,接受OSU COM硕士的教学培训,
医学科学高级学位课程,并参加专业发展活动。以下
完成研究培训计划后,学员将继续进行另外两到三年的高级培训,
临床训练在此期间,他们继续出版,出席全国会议,竞争奖项
并参与与该计划相关的研究和专业发展活动。与此
更新申请,我们正在申请资金,每年培训四名博士后学员,第一年
到5。获得MMS学位的核心要求包括免疫学,研究设计,
生物统计学,资助写作和研究伦理学。学员还必须参加两个新开发的
课程“外科医生职业发展”课程和“免疫学在外科手术中的应用”期刊俱乐部。
重要的计划注意力是针对临床和研究培训的无缝集成
计划,确保课程的质量和严谨性,促进提高科学的机会
沟通技巧,创造创新的教育评估工具,仔细评估个人
学员的进步和对计划成果的集体评估。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
GINNY L BUMGARDNER其他文献
GINNY L BUMGARDNER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('GINNY L BUMGARDNER', 18)}}的其他基金
CTSA Predoctoral T32 at the Ohio State University
俄亥俄州立大学 CTSA 博士前 T32
- 批准号:
10705448 - 财政年份:2023
- 资助金额:
$ 33.69万 - 项目类别:
Medical Scientist Training Program - The Ohio State University
医学科学家培训计划 - 俄亥俄州立大学
- 批准号:
10681215 - 财政年份:2021
- 资助金额:
$ 33.69万 - 项目类别:
Medical Scientist Training Program - The Ohio State University
医学科学家培训计划 - 俄亥俄州立大学
- 批准号:
10270657 - 财政年份:2021
- 资助金额:
$ 33.69万 - 项目类别:
Medical Scientist Training Program - The Ohio State University
医学科学家培训计划 - 俄亥俄州立大学
- 批准号:
10430249 - 财政年份:2021
- 资助金额:
$ 33.69万 - 项目类别:
Medical Scientist Training Program - The Ohio State University
医学科学家培训计划 - 俄亥俄州立大学
- 批准号:
10438948 - 财政年份:2021
- 资助金额:
$ 33.69万 - 项目类别:
Investigating a Novel Cellular Therapy to Prevent and Treat Acute Antibody Mediated Kidney Transplant Rejection
研究预防和治疗急性抗体介导的肾移植排斥反应的新型细胞疗法
- 批准号:
10203783 - 财政年份:2019
- 资助金额:
$ 33.69万 - 项目类别:
Investigating a Novel Cellular Therapy to Prevent and Treat Acute Antibody Mediated Kidney Transplant Rejection
研究预防和治疗急性抗体介导的肾移植排斥反应的新型细胞疗法
- 批准号:
10436921 - 财政年份:2019
- 资助金额:
$ 33.69万 - 项目类别:
Investigating a Novel Cellular Therapy to Prevent and Treat Acute Antibody Mediated Kidney Transplant Rejection
研究预防和治疗急性抗体介导的肾移植排斥反应的新型细胞疗法
- 批准号:
10653007 - 财政年份:2019
- 资助金额:
$ 33.69万 - 项目类别: